Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Hudson, Hiroyuki Mitani, Daniel Kisner, Harry Hixson, Affymetrix, ParAllele Bioscience

Premium

People in the News

Thomas Hudson has been named to the scientific advisory board of Biopotential Capital, the Calgary, Alberta-based venture capital firm said June 14.

Hudson is an associate professor and associate physician in the departments of medicine & human genetics at McGill University and is the founder and director of the McGill University and Genome Quebec Innovation Centre. He is also the editor-in-chief of the journal Human Genetics.

Hudson formerly served as assistant director of the Whitehead Institute/MIT Center for Genome Research and chaired the Science Committee of Genome Canada.


Hiroyuki Mitani has been appointed president and CEO of GE Healthcare Technologies, Japan. Mitani joined GE Japan in 1992 as director of business development. Prior to his current role, he served as general manager of marketing and sales for GE Transportation, Japan. In 1996, he served as general manager of marketing and sales for GE Energy, Japan.

Mitani received his MS in operations research from Stanford University in 1984 and an MS in mechanical engineering from the University of California, Berkeley, in 1983. He received his BS in mechanical engineering from the University of Tokyo in 1977.


Daniel Kisner has resigned from the board of directors of Sequenom, according to an SEC filing dated June 15.

Kisner had served as a member the company's audit committee. Harry Hixson, one of Sequenom's independent directors, will fill the vacancy on the audit committee, the company said.

 

Products

Affymetrix has released its GeneChip Scanner 3000 7G, an upgraded version of its GCS 3000, which can be configured as part of the GCS 3000 MegAllele System, and supports multiplexed assays for custom genotyping developed using ParAllele Bioscience's molecular inversion probe technology.

Affy signed an agreement to acquire ParAllele earlier this month. According to Affymetrix, the new scanner supports four color scanning for use in MegAllele assays, fits into a benchtop environment, uses a solid state laser, and supports newer high-density Affymetrix GeneChip microarrays for tiling, all-exon, and SNP genotyping research.

The scanner also includes a dual processor workstation and software updates for processing and analyzing the data generated per experiment. Users can either purchase the new system or request an upgrade to include the new scanner, Affy said.

 

Correction

The BioArray CGH Labeling System for comparative genomic hybridization launched earlier this month by Enzo Life Sciences does not include bacterial artificial chromosome arrays.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.